Anteris Technologies Ltd (ASX:AVR) Share Price and News - StockTrack

Market Cap (4-Jul) $220,044,640 (813th)	Close (30-Jun) $21.37 0 (0%)	Volume (30-Jun) 14,319	Shortsold (11-Apr) 86 (0.00%) (618th)
52w High $18.29	52w Low $4.26	P/E -	EPS -5.27

	Subject
	AVR AVR Ann: DurAVR FIH 30-Day Study Results Presented at TCT Boston
	1 (current) 2 3
	AVR AVR Ann: Results Demonstrating Restoration of Normal Pre-Disease Flow
	AVR AVR Ann: Transcatheter Cardiovascular Therapeutics Conference
	AVR AVR Ann: Anteris Hosts Australian Interventional Cardiology Experts
	AVR AVR Ann: Cleansing Notice
	AVR AVR Ann: Application for quotation of securities - AVR
	AVR AVR Ann: Cleansing Notice
	AVR AVR Ann: Appendix 4D and Half Year Financial Report Announcement
	AVR AVR Ann: Appendix 4D and Half Year Financial Report
	AVR AVR Ann: Application for quotation of securities - AVR
	AVR AVR Ann: Cleansing Notice
	AVR AVR Ann: Application for quotation of securities - AVR
	AVR AVR Ann: Change in substantial holding
	AVR AVR Ann: Notification of cessation of securities - AVR
	AVR AVR Ann: Cleansing Notice
	AVR AVR Ann: Application for quotation of securities - AVR
	AVR AVR Ann: Third Conversion of Securities - Mercer
	AVR AVR Ann: Appendix 4C Clarification and Upcoming Milestones
	AVR AVR Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	AVR AVR Ann: Dr. Martin Leon, MD Joins Global Medical Advisory Board
	AVR AVR Ann: Update on First In Human DurAVR THV Study
	AVR AVR Ann: Cleansing Notice
	AVR AVR Ann: Application for quotation of securities - AVR
	AVR AVR Ann: Notification regarding unquoted securities - AVR
	AVR AVR Ann: Notification of cessation of securities - AVR
	AVR AVR Ann: Application for quotation of securities - AVR
	AVR AVR Ann: DurAVR First In Human Patient 6 Month Study Follow Up
	AVR AVR Ann: Cleansing Notice
	AVR AVR Ann: Application for quotation of securities - AVR
	AVR AVR Ann: Change of Director's Interest Notice x4
	AVR AVR Ann: Notification regarding unquoted securities - AVR
	AVR AVR Ann: Cleansing Notice
	AVR AVR Ann: Application for quotation of securities - AVR
	AVR AVR Ann: Application for quotation of securities - AVR
	AVR AVR Ann: Second Conversion of Securities - Mercer
	AVR AVR Ann: Successful Completion of Second First-In-Human Study
	AVR AVR Ann: EXPANSION OF FIRST IN HUMAN TRIAL
	AVR AVR Ann: Results of Meeting
	AVR AVR Ann: AGM Chairman Address and CEO Presentation
	AVR AVR Ann: Expansion of Medical Advisory Board
	AVR AVR Ann: Application for quotation of securities - AVR
	AVR AVR Ann: Conversion of Securities - Mercer
	AVR AVR Ann: Notification of cessation of securities - AVR
	AVR AVR Ann: Cleansing Notice
	AVR AVR Ann: Application for quotation of securities - AVR
	AVR AVR Ann: Notification regarding unquoted securities - AVR
	AVR AVR Ann: Research Partnership with Yale University and YCRG
	AVR AVR Ann: Notice of General Meeting/Proxy Form
	AVR AVR Ann: Corporate Governance Statement and Appendix 4G
	AVR AVR Ann: Annual Report to shareholders

Similar Companies

Ansell

ANN

Medigard

MGZ

Nanosonics

NAN

Next Science

NXS

Osteopore

OSX

PolyNovo

PNV

SDI

End of Day Prices

Date	Close	Volume	Change
03-Jul	$5.62	10,913	-0.08 (1.40%)
02-Jul	$5.70	16,614	-0.44 (7.17%)
30-Jun	$6.14	797	-0.13 (2.07%)
27-Jun	$6.27	17,398	+0.36 (6.09%)
26-Jun	$5.91	7,430	-0.24 (3.90%)
24-Jun	$6.15	6,816	+0.15 (2.50%)
23-Jun	$6.00	14,321	-0.03 (0.50%)
20-Jun	$6.03	8,792	+0.01 (0.17%)
19-Jun	$6.02	12,995	-0.03 (0.50%)
18-Jun	$6.05	15,980	-0.60 (9.02%)
16-Jun	$6.65	33,562	-0.50 (6.99%)
13-Jun	$7.15	19,694	-0.30 (4.03%)
12-Jun	$7.45	43,266	+0.45 (6.43%)
06-Jun	$7.00	26,619	+0.20 (2.94%)
05-Jun	$6.80	12,029	+0.35 (5.43%)
6 up, 9 down, and 0 flat days

High $21.50	Low $21.07	Trades 54	Turnover $305,963	Volume 14,319
30 June 2023 at 4:24pm

High $21.50	Low $21.07	Trades 54	Turnover $305,963	Volume 14,319
30 June 2023 at 4:24pm

Anteris Technologies Ltd Health Care

$21.37 0.02 (0.09%)

$21.37 0.02 (0.09%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices